Current role
Shell Companies · Financial Services
CFO, Chief Accounting Officer
2025-11-17–present
Saleem Elmasri
Chief Accounting Officer
Drugs Made In America Acquisition II Corp. (DMII)Equibles does not estimate personal net worth.
Get an email with a short summary when Drugs Made In America Acquisition II Corp. publishes a filing, an earnings call transcript or a press release.
Get DMII alertsAbout Saleem Elmasri
Saleem Elmasri is recorded as CFO and Chief Accounting Officer at Drugs Made In America Acquisition II Corp. (DMII) since November 17, 2025. Drugs Made In America Acquisition II Corp. reported in an 8-K filed November 18, 2025 that Saleem Elmasri was appointed principal financial and accounting officer, effective November 17, 2025. Drugs Made In America Acquisition II Corp. reported in an 8-K filed November 18, 2025 that Saleem Elmasri was appointed Chief Financial Officer, effective November 17, 2025. Drugs Made In America Acquisition II Corp. is classified in the Shell Companies industry within the Financial Services sector. Other leadership on record at Drugs Made In America Acquisition II Corp. includes Roger Bendelac (CEO), Catherine Do (Board Member), G. Sridhar Prasad (Board Member) and 1 other.
“Mr. Elmasri's appointment to principal financial and accounting officer of the Company will be effective beginning November 17, 2025.”
“On November 17, 2025, the Company appointed Saleem Elmasri as Chief Financial Officer and principal financial and accounting officer of the Company and entered into a Master Services Agreement (the "Consulting Agreement") with Titan Advisory Services LLC for the provision of such principal financial and accounting officer services by Mr. Elmasri.”
Affiliation history
-
Current
2025-11-17–present
-
Current
2025-11-17–present
Company network
Leadership on record at Drugs Made In America Acquisition II Corp.
- Roger Bendelac CEO
- Catherine Do Board Member
- G. Sridhar Prasad Board Member
- Myron W. Shulgan Board Member